NPC2 and cancer: Based on the overall level of the interactive BodyMap, we discovered that the expression levels of NPC2 and ITGAV in most human cancers and comparable normal tissues varied, notably in the digestive organs (esophagus, pancreas, liver, and stomach), as well as the brain, blood, thyroid, and other organs and tissues (Figure 3A,B).